Role of the fibrinolytic system in preventing myocardial infarction

被引:29
作者
Vaughan, DE
Rouleau, JL
Pfeffer, MA
机构
[1] VET AFFAIRS MED CTR, NASHVILLE, TN 37212 USA
[2] MONTREAL HEART INST, MONTREAL, PQ H1T 1C8, CANADA
[3] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV CARDIOVASC, BOSTON, MA 02115 USA
关键词
fibrinolysis; renin-angiotensin system; plasminogen activator inhibitor-1; tissue-type plasminogen activator; angiotensin converting enzyme;
D O I
10.1093/eurheartj/16.suppl_K.31
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activation of the renin-angiotensin system (RAS) has been implicated in the pathogenesis of acute myocardial infarction (AMI). Similarly, reduced fibrinolytic activity has been associated with an increased risk of AMI. Evidence is now accumulating that the RAS plays an important role in the regulation of fibrinolysis and that pharmacological interruption of the RAS exerts a positive effect on endogenous fibrinolytic balance. This relationship appears to provide a partial explanation for the newly recognized effect of angiotensin converting enzyme inhibitors in preventing AMI.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 30 条
[1]   ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].
ALDERMAN, MH ;
MADHAVAN, S ;
OOI, WL ;
COHEN, H ;
SEALEY, JE ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104
[2]  
BELL L, 1990, AM J PATHOL, V137, P7
[3]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[4]   ANTIATHEROGENIC EFFECT OF CAPTOPRIL IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
CHOBANIAN, AV ;
HAUDENSCHILD, CC ;
NICKERSON, C ;
DRAGO, R .
HYPERTENSION, 1990, 15 (03) :327-331
[5]   LACK OF REFLEX INCREASE IN MYOCARDIAL SYMPATHETIC TONE AFTER CAPTOPRIL - POTENTIAL ANTIANGINAL EFFECT [J].
DALY, P ;
METTAUER, B ;
ROULEAU, JL ;
COUSINEAU, D ;
BURGESS, JH .
CIRCULATION, 1985, 71 (02) :317-325
[6]   BRIEF REPORT - COMPLETE DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DUE TO A FRAME-SHIFT MUTATION [J].
FAY, WP ;
SHAPIRO, AD ;
SHIH, JL ;
SCHLEEF, RR ;
GINSBURG, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1729-1733
[7]   ANGIOTENSIN-2 STIMULATION OF PROSTAGLANDIN PRODUCTION IN CULTURED HUMAN VASCULAR ENDOTHELIUM [J].
GIMBRONE, MA ;
ALEXANDER, RW .
SCIENCE, 1975, 189 (4198) :219-220
[8]  
HAMSTEN A, 1987, LANCET, V2, P3
[9]   ENALAPRIL RELATED CHANGES IN THE FIBRINOLYTIC SYSTEM IN SURVIVORS OF MYOCARDIAL-INFARCTION [J].
JANSSON, JH ;
BOMAN, K ;
NILSSON, TK .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (05) :485-488
[10]  
KJELSBERG MO, 1985, AM J CARDIOL, V55, P1